REASSESSMENT OF CARDIAC FUNCTION AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR USE AMONG MEDICARE PATIENTS WITH LOW EJECTION FRACTION AFTER MYOCARDIAL INFARCTION

被引：1
|
作者：
Pokorney, Sean [1 ]
Miller, Amy Leigh [1 ]
Chen, Anita [1 ]
Thomas, Laine [1 ]
Fonarow, Gregg [1 ]
de Lemos, James [1 ]
Al-Khatib, Sana [1 ]
Peterson, Eric [1 ]
Wang, Tracy [1 ]
机构：
[1] Duke Clin Res Inst, Durham, NC USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)60453-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1253-240
引用
收藏
页码：A453 / A453
页数：1
相关论文
共 50 条
  • [21] Indications for implantable cardioverter-defibrillator placement in ischemic cardiomyopathy and after myocardial infarction
    Mountantonakis S.E.
    Hutchinson M.D.
    Current Heart Failure Reports, 2011, 8 (4) : 252 - 259
  • [22] Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
    Rasmus Rørth
    Pooja Dewan
    Søren Lund Kristensen
    Pardeep S. Jhund
    Mark C. Petrie
    Lars Køber
    John J. V. McMurray
    Clinical Research in Cardiology, 2019, 108 : 868 - 877
  • [23] Wearable Cardioverter-Defibrillator after Myocardial Infarction
    Fauchier, Laurent
    Clementy, Nicolas
    Bisson, Arnaud
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06): : 599 - 600
  • [24] Wearable Cardioverter-Defibrillator after Myocardial Infarction
    Olgin, Jeffrey E.
    Pletcher, Mark J.
    Vittinghoff, Eric
    Wranicz, Jerzy
    Malik, Rajesh
    Morin, Daniel P.
    Zweibel, Steven
    Buxton, Alfred E.
    Elayi, Claude S.
    Chung, Eugene H.
    Rashba, Eric
    Borggrefe, Martin
    Hue, Trisha F.
    Maguire, Carol
    Lin, Feng
    Simon, Joel A.
    Hulley, Stephen
    Lee, Byron K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (13): : 1205 - 1215
  • [25] Factors Associated With Implantable Cardioverter-Defibrillator Placement Among US Veterans With Left Ventricular Ejection Fraction ≤35% at Least 40 Days After Acute Myocardial Infarction
    Judson, Gregory L.
    Cohen, Beth
    Muniyappa, Anoop
    Raitt, Merritt
    Shen, Hui
    Tarasovsky, Gary
    Whooley, Mary
    Dhruva, Sanket
    CIRCULATION, 2020, 142
  • [26] Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis
    Varr, Brandon C.
    Zarafshar, Shirin
    Coakley, Terra
    Liedtke, Michaela
    Lafayette, Richard A.
    Arai, Sally
    Schrier, Stanley L.
    Witteles, Ronald M.
    HEART RHYTHM, 2014, 11 (01) : 158 - 162
  • [27] Effect of Implantable Cardioverter-Defibrillator on Left Ventricular Ejection Fraction in Patients With Idiopathic Dilated Cardiomyopathy
    Schaer, Beat
    Theuns, Dominic A.
    Sticherling, Christian
    Szili-Torok, Tamas
    Osswald, Stefan
    Jordaens, Luc
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (11): : 1640 - 1645
  • [28] Optimal Timing of Implantable Cardioverter-Defibrillator Implantation After Myocardial Infarction: A Decision Analysis
    Piccini, Jonathan P.
    Al-Khatib, Sana M.
    Myers, Evan R.
    Anstrom, Kevin J.
    Buxton, Alfred E.
    Peterson, Eric D.
    Sanders, Gillian D.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (07) : 791 - 798
  • [29] Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator
    Kim, Eun-Jeong
    Holmes, Benjamin B.
    Huang, Shi
    Lugo, Ricardo
    Al Aboud, Asad
    Goodman, Stacey
    Hung, Rebecca R.
    Slosky, David
    Stevenson, William G.
    Michaud, Gregory F.
    John, Roy M.
    EUROPACE, 2020, 22 (08): : 1216 - 1223
  • [30] Wearable Cardioverter-Defibrillator after Myocardial Infarction REPLY
    Lee, Byron K.
    Pletcher, Mark J.
    Olgin, Jeffrey E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (06): : 600 - 601
12345